O
SIBN icon

OrbiMed’s SI-BONE Inc SIBN Stock Holding History

OrbiMed’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,578,979
Closed -$38M – 126
2025
Q3 		$38M Hold
2,578,979
– – 0.89% 37
2025
Q2 		$48.5M Sell
2,578,979
-863,874
-25% -$14.3M 1.21% 25
2025
Q1 		$48.3M Hold
3,442,853
– – 1.15% 26
2024
Q4 		$48.3M Buy
3,442,853
+137,052
+4% +$1.84M 0.99% 30
2024
Q3 		$46.2M Buy
3,305,801
+75,824
+2% +$1.14M 0.84% 37
2024
Q2 		$41.8M Buy
3,229,977
+55,456
+2% +$792K 0.82% 37
2024
Q1 		$52M Buy
3,174,521
+881,990
+38% +$16.6M 0.95% 36
2023
Q4 		$48.1M Hold
2,292,531
– – 0.96% 39
2023
Q3 		$48.7M Hold
2,292,531
– – 1.03% 33
2023
Q2 		$61.9M Sell
2,292,531
-626,923
-21% -$15.3M 1.12% 34
2023
Q1 		$57.4M Sell
2,919,454
-448,546
-13% -$7.97M 1.13% 27
2022
Q4 		$45.8M Hold
3,368,000
– – 0.88% 43
2022
Q3 		$58.8M Hold
3,368,000
– – 1.09% 34
2022
Q2 		$44.5M Buy
3,368,000
+228,753
+7% +$3.81M 0.81% 41
2022
Q1 		$70.9M Buy
3,139,247
+833,947
+36% +$17.3M 1.15% 30
2021
Q4 		$51.2M Buy
2,305,300
+57,300
+3% +$1.23M 0.66% 48
2021
Q3 		$48.2M Buy
2,248,000
+942,700
+72% +$23.9M 0.53% 52
2021
Q2 		$41.1M Hold
1,305,300
– – 0.42% 67
2021
Q1 		$41.5M Sell
1,305,300
-63,200
-5% -$1.94M 0.39% 70
2020
Q4 		$40.9M Hold
1,368,500
– – 0.36% 66
2020
Q3 		$32.5M Sell
1,368,500
-12,800
-0.9% -$254K 0.41% 65
2020
Q2 		$22M Hold
1,381,300
– – 0.31% 72
2020
Q1 		$16.5M Buy
+1,381,300
New +$25.4M 0.28% 73
2019
Q4 		– Sell
-422,000
Closed -$7.46M – 144
2019
Q3 		$7.46M Sell
422,000
-563,368
-57% -$10.8M 0.14% 84
2019
Q2 		$20M Hold
985,368
– – 0.31% 71
2019
Q1 		$18.6M Hold
985,368
– – 0.29% 77
2018
Q4 		$20.6M Buy
+985,368
New +$18.6M 0.38% 67

Other funds holding SIBN

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

OrbiMed's SIBN Position: Q4 2025 in Review

OrbiMed sold out of SI-BONE Inc (SIBN) in Q4 2025, closing a stake of 2,578,979 shares — an estimated $38M sold.

OrbiMed first reported a position in SIBN in Q4 2018 and held it in 27 quarters. The position peaked at $70.9M in Q1 2022. 182 funds tracked by Wall St. Rank hold SIBN as of Q4 2025.

  • OrbiMed reported no remaining SI-BONE Inc position as of Q4 2025 after selling out during the quarter.
  • OrbiMed sold 2,578,979 SI-BONE Inc shares in Q4 2025, an estimated $38M.
  • OrbiMed first reported a position in SI-BONE Inc in Q4 2018 and held it in 27 quarters.
  • OrbiMed's SI-BONE Inc position peaked at $70.9M in Q1 2022.
  • 182 funds tracked by Wall St. Rank held SI-BONE Inc as of Q4 2025.

Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.